Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELIGLUSTAT vs ELIQUIS: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ELIGLUSTAT vs ELIQUIS: Safety Overview

Metric ELIGLUSTAT ELIQUIS
Total FAERS Reports 1,368 1,430
Deaths Reported 18 98
Death Rate 1.3% 6.9%
Hospitalizations 173 273
Average Patient Age 48.6 yrs 76.5 yrs
% Female Patients 57.1% 100.0%
FDA Approval Date Aug 17, 2022 N/A
Manufacturer Genzyme Corporation N/A
Route ORAL N/A
Marketing Status Prescription N/A